© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 161 Farringdon Rd, London EC1R 3AL. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions | Cookies

Health and Biotech

Top Section/Ad
More articles/Ad

More articles/Ad

More articles

  • SSA
    Investors in the SSA market are piling into long dated bonds, leaving aside any coronavirus-driven fears and swelling the order books on 30 year and 50 year paper to record breaking levels, in what bankers are calling a 'one way market'.
  • Canada’s DRI Capital is preparing to list a new fund on the London Stock Exchange focused on investing in pharmaceuticals royalties.
  • The value of the riskier tranche of the World Bank’s pandemic bond has been discounted — but not by very much — as the coronavirus outbreak infects more people outside of China and therefore comes closer to triggering a payout from the notes.
  • EMEA equity capital markets roared back into life this week, as fears over a potential coronavirus pandemic abated to allow the blocks market to reopen in size. A huge slug of supply on Monday evening that traded up left investors hungry for more, report Sam Kerr and Aidan Gregory.
  • Dr Suliaman Al Habib Medical Group, one of the largest private health companies in Saudi Arabia, has announced it is seeking to list on the Tadawul stock exchange. It is the first company to attempt an IPO there since the record listing of Saudi Aramco last December.
  • ABS
    Investors are looking for more yield on aircraft ABS paper as fear over the coronavirus intensifies globally. With Asia taking up a bigger share of global air travel than during the SARS outbreak in 2003, investors expect the coronavirus to have a bigger impact on the market.